Events

Control of strategic goods: Basic training dual-use goods
NOV
Thu
12
09:30 - 11:45

Starts in 8 months from now

Location

Online

Programmes
Defence EDF NATO-EDA Space

Attendees can expect to gain insights into regulations and best practices on dual-use goods relevant to their sectors.

Two online sessions of this basic training on dual-use goods are planned on 26 February and 12 November 2026 from 9:30 to 11:45. One physical session is planned on 10 June in the offices of the Strategic Goods Control Unit in Brussels.

For defence-related goods, three separate online sessions are planned on 24 March, 23 June and 6 October.

For more information and Registration: Opleidingen dual use voor beginners 2026 | Departement

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.